Teva Announces U.S. Launch of QVAR® RediHaler™ (Beclomethasone Dipropionate HFA) Inhalation Aerosol | Placera
Teva's proposed opioid settlement could cost drugmaker pennies on the dollar | Reuters
Company presentation
ANNUAL REPORT 2017
January 2017 – GlobalStockPicking.com
TEVA PHARMACEUTICAL INDUSTRIES LIMITED : Precio Acción Bourse | TEVA | IL0006290147 | MarketScreener
Teva hopes to launch migraine drug as soon as September | Reuters
Avanza Bank – GlobalStockPicking.com
Oasmia Pharmaceutical — An appealing metamorphosis - Edison Group
Israel's Teva Pharm to raise $5 billion in debt securities | Reuters
Foreign Direct Investment in Latin America and the Caribbean 2022 by Publicaciones de la CEPAL, Naciones Unidas - Issuu
Does the United States have the largest pharmaceutical industry in the world because it is the sickest industrial country or is it the sickest country because it has the largest pharmaceutical industry? -
Global Asset Purchase Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2015 to 2022
KEY EVENTS & TRENDS
Pharma's Almanac Q2 2016 Edition
Avanzanite Bioscience Launches Novel Business Model to Commercialize Innovative Medicines for Rare Diseases in Europe | Business Wire
Ediciones VR - Teva Pharmaceuticals avanza con Cinqaero
Israel's Teva seeks partners for new drugs to relieve pressure | Reuters
New England Diary | Blog
Drugmakers aim big price hikes at U.S. patients, congressional report finds | Reuters
Teva Announces New Organization Structure and Leadership Changes | Placera
Teva to discontinue study for chronic headache treatment | Reuters
KEY EVENTS & TRENDS
All news articles for December 2018
